The rapid adoption of GLP-1 medications has created unprecedented challenges for payers as they balance clinical effectiveness with financial sustainability
Comprehensive Theory Training (1+ Hour Presentation) A detailed breakdown of fat dissolving science, product behaviour, safety considerations, anatomy, contraindications and treatment planning giving you a complete understanding of why each step matters, not just how to perform it
Gastrointestinal Side Effects: The Frequent Flier GI issues are the most commonly reported side effects of GLP-1 medicationsand theyre not subtle
Vegetarians and vegans especially need to be careful and consider supplements, as most common vitamin B12 food sources do not fit with these diets
For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage
Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches
